GLP-SEM is a 31-amino-acid GLP-1 receptor agonist analog studied for its roles in incretin signaling pathways, glucose homeostasis regulation, and appetite-related neuroendocrine modulation. A widely characterized compound in metabolic and endocrinology research literature.